We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Isis Earns $1M From GSK for Advancing Hepatitis B Virus Program

News   Jul 03, 2014

 
Isis Earns $1M From GSK for Advancing Hepatitis B Virus Program
 
 
 

RELATED ARTICLES

75,000-molecule Screen Reveals Amyloid-reducing Compound

News

Researchers have uncovered an enzyme and a biochemical pathway they believe may lead to the identification of drugs that could inhibit the production of beta-amyloid protein, the toxic initiator of Alzheimer’s disease (AD).

READ MORE

Compound Could Help Treat Ovarian Cancer

News

Scientists from the University of Sheffield have discovered a compound that could be more effective in treating certain cancers than standard chemotherapy.

READ MORE

Engineered "Suicide Genes" Safely Grow Beta Cells From Stem Cells

News

A human pluripotent stem cell line has been engineered which contains two ‘suicide genes’ that induce cell death in all but the desired insulin-producing cells. This double fail-safe approach opens the door to creating safe cell-replacement therapies for people living with type 1 diabetes.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE